The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
RRIA (Rapid Response Innovation Awards), 2013Role of GSK-3beta in Parkinson’s Disease
The protein GSK-3beta has not previously been linked to Parkinson’s disease (PD). Recently, we have studied pre-clinical models with high levels of GSK-3beta throughout the brain. At a younger age [up...
-
MJFF Research Grant, 2013Validation and Characterization of Exosomal Alpha-synuclein as a Diagnostic Marker for Parkinson’s Disease
Parkinson’s disease (PD) is characterized by aggregation of the intracellular alpha-synuclein protein and subsequent neurodegeneration. Recent findings suggest that extracellular alpha-synuclein forms...
-
Research Grant, 2013Ubiquitous, Inexpensive Non-invasive Technologies for Objective Detection and Monitoring of Parkinson’s Symptoms
Objective/Rationale:
For doctors to diagnose and treat Parkinson’s, they need reliable tests. Unfortunately, testing the symptoms of Parkinson’s at a specialist’s office/clinic is expensive and time... -
Research Grant, 2013Prion-like Dissemination of Synuclein Pathology: A Non-human Study
Objective/Rationale:
Parkinson’s disease (PD) is characterized by the loss of midbrain dopaminergic neurons and the presence of aggregates named Lewy bodies. This pathology is believed to drive the... -
Research Grant, 2013Mu Opioid Receptor Target for Levodopa-Induced Dyskinesia: Stop or Continue? (MOR4LID)
Objective/Rationale:
The mu opioid receptor (MOR) has long been proposed as an appealing target for managing levodopa-induced dyskinesia and therefore received attention from industry, which developed... -
Target Validation, 2013PARK14: Validation of a New Pre-clinical Model of Age-dependent PD
Objective/Rationale:
The gene PARK 14 (PLA2g6) is expressed in human brain, and numerous mutations in this gene were found to be associated with PD, but the mechanism of such association is...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.